| abstract |
Disclosed is a prophylactic or therapeutic agent for diabetes that inhibits SGLT1 activity and suppresses absorption of glucose and the like to prevent diabetes or suppress postprandial hyperglycemia in diabetes. A compound represented by the following formula (I): [Wherein, X is a hydrogen atom or a C 1-6 alkyl group, and Y is a C 1-6 alkylene group, or —O— (CH 2 ) n — (n is an integer of 1 to 5). Z represents —CONHR A or —NHCONHR B (wherein n is not 1 when Z represents —NHCONHR B ). Where R A is a C 1-6 alkyl group substituted with 1 to 3 groups selected from the group consisting of a hydroxyl group and —CONH 2 , and R B is a hydrogen atom, or a hydroxyl group and —CONH 2. A C 1-6 alkyl group substituted with 1 to 3 groups selected from the group consisting of] [Selection figure] None |